Second-Generation Antihistamines
Indian Journal of Drugs in Dermatology · 2016
DOI: 10.4103/2455-3972.184094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Drugs in Dermatology, 2016. Verfasst von Pranjal Anil Mittal und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Abstract (Originalsprache)
Clinical trials have proved the efficacy of antihistamines in the treatment of chronic idiopathic urticarial (CIU). Second-generation antihistamines are recommended as first-line therapy for CIU. This article reviews the newer second-generation antihistamines in light of recent advances in the understanding of their pharmacology, efficacy, and safety profile. A Google scholar search for second-generation antihistamines was done using the words “second generation H 1 antihistamines,” “bilastine,” “ebastine,” “olopatadine,” “rupatadine,” “levocetirizine,” “fexofenadine,” “desloratadine,” “histamine,” “allergy,” and “urticaria.” All the articles were retrieved and classified into review articles, studies, double-blinded trials, and case reports. The final data were then analyzed and presented in a narrative fashion.
Zitieren
APA
Mittal, P. A., Godse, K. V., & Patil, S. P. (2016). Second-Generation Antihistamines. Indian Journal of Drugs in Dermatology. https://doi.org/10.4103/2455-3972.184094
Vancouver
Mittal PA, Godse KV, Patil SP. Second-Generation Antihistamines. Indian Journal of Drugs in Dermatology. 2016. doi:10.4103/2455-3972.184094
BibTeX
@article{Mittal2016,
author = {Mittal, Pranjal Anil and Godse, Kiran V and Patil, Sharmila P},
title = {Second-Generation Antihistamines},
journal = {Indian Journal of Drugs in Dermatology},
year = {2016},
doi = {10.4103/2455-3972.184094}
}
EUVIMED